Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Showing 1 to 4 of 4 results for teprotumumab

  1. Teprotumumab for treating thyroid eye disease [ID6432]

    Deferred Reference number: GID-TA11531

    Technology appraisal guidance
    Deferred

  2. Teprotumumab for treating thyroid eye disease (deferred appraisal of D1) [ID6756]

    In development Reference number: GID-TA11995 Expected publication date: TBC

    Technology appraisal guidance
    In development

  3. Deferred

    Find out what guidance is being considered for development

  4. Forward view - our priority topics

    Our forward view highlights the areas we will prioritise in the coming year.